Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase‐2 and vascular endothelial growth factor expression
Publisher: John Wiley & Sons Inc
E-ISSN: 1442-9071|43|5|458-465
ISSN: 1442-6404
Source: CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol.43, Iss.5, 2015-07, pp. : 458-465
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract